296
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Clinical Characteristics, Glycemic Control, and Microvascular Complications Compared Between Young-Onset Type 1 and Type 2 Diabetes Patients at Siriraj Hospital – A Tertiary Referral Center

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 1375-1387 | Published online: 02 May 2022

References

  • Lin X, Xu Y, Pan X, et al. Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Sci Rep. 2020;10(1):14790. doi:10.1038/s41598-020-71908-9
  • DiMeglio LA, Evans-Molina C, Oram RA. Type 1 diabetes. Lancet. 2018;391(10138):2449–2462. doi:10.1016/S0140-6736(18)31320-5
  • Lascar N, Brown J, Pattison H, Barnett AH, Bailey CJ, Bellary S. Type 2 diabetes in adolescents and young adults. Lancet Diabetes Endocrinol. 2018;6(1):69–80. doi:10.1016/S2213-8587(17)30186-9
  • Tuchinda C, Likitmaskul S, Unachak K, Panamonta O, Patarakijavanich N, Chetthakul T. The epidemiology of type 1 diabetes in Thai children. J Med Assoc Thai. 2002;85(6):648–652.
  • Aekplakorn W. The 4th Thai National Health Examination Survey 2008–2009. Nonthaburi: The graphic publisher; 2009.
  • Aekplakorn W. The 6th Thai National Health Examination Survey 2019–2020. Nonthaburi: The graphic publisher; 2020.
  • Reinehr T. Type 2 diabetes mellitus in children and adolescents. World J Diabetes. 2013;4(6):270–281. doi:10.4239/wjd.v4.i6.270
  • DiMeglio LA, Acerini CL, Codner E, et al. ISPAD clinical practice consensus guidelines 2018: glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes. Pediatr Diabetes. 2018;19(Suppl 27):105–114. doi:10.1111/pedi.12737
  • Zeitler P, Arslanian S, Fu J, et al. ISPAD clinical practice consensus guidelines 2018: type 2 diabetes mellitus in youth. Pediatr Diabetes. 2018;19(Suppl 27):28–46. doi:10.1111/pedi.12719
  • Barr MM, Aslibekyan S, Ashraf AP. Glycemic control and lipid outcomes in children and adolescents with type 2 diabetes. PLoS One. 2019;14(7):e0219144–e0219144. doi:10.1371/journal.pone.0219144
  • Weinstock RS, Braffett BH, Songer TJ. Health care coverage and glycemic control in young adults with youth-onset type 2 diabetes: results from the TODAY2 study. Diabetes Care. 2020;43(10):2469–2477. doi:10.2337/dc20-0760
  • Dabelea D, Stafford JM, Mayer-Davis EJ, et al. Association of type 1 diabetes vs type 2 diabetes diagnosed during childhood and adolescence with complications during teenage years and young adulthood. JAMA. 2017;317(8):825–835. doi:10.1001/jama.2017.0686
  • Dejkhamron P, Santiprabhob J, Likitmaskul S, et al. Type 1 diabetes management and outcomes: a multicenter study in Thailand. J Diabetes Investig. 2021;12(4):516–526. doi:10.1111/jdi.13390
  • American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes—2019. Diabetes Care. 2019;42(Supplement 1):S13–S28. doi:10.2337/dc19-S002
  • Donaghue KC, Marcovecchio ML, Wadwa RP, et al. ISPAD clinical practice consensus guidelines 2018: microvascular and macrovascular complications in children and adolescents. Pediatr Diabetes. 2018;19(S27):262–274. doi:10.1111/pedi.12742
  • Rogers MAM, Kim C, Banerjee T, Lee JM. Fluctuations in the incidence of type 1 diabetes in the United States from 2001 to 2015: a longitudinal study. BMC Med. 2017;15(1):199. doi:10.1186/s12916-017-0958-6
  • Forga Llenas L, Goñi Iriarte MJ, Cambra Contin K, Ibáñez Beroiz B, Chueca Guendulain M, Berrade Zubiri S. Incidence and temporal trends of childhood type 1 diabetes between 1975 and 2012 in Navarre (Spain). Gac Sanit. 2015;29(1):51–54. doi:10.1016/j.gaceta.2014.06.010
  • Reinehr T. Clinical presentation of type 2 diabetes mellitus in children and adolescents. Int J Obes. 2005;29(2):S105–S110. doi:10.1038/sj.ijo.0803065
  • Choleau C, Maitre J, Filipovic Pierucci A, et al. Ketoacidosis at diagnosis of type 1 diabetes in French children and adolescents. Diabetes Metab. 2014;40(2):137–142. doi:10.1016/j.diabet.2013.11.001
  • Oyarzabal Irigoyen M, García Cuartero B, Barrio Castellanos R, et al. Ketoacidosis at onset of type 1 diabetes mellitus in pediatric age in Spain and review of the literature. Pediatr Endocrinol Rev. 2012;9(3):669–671.
  • Kao KT, Islam N, Fox DA, Amed S. Incidence trends of diabetic ketoacidosis in children and adolescents with type 1 diabetes in British Columbia, Canada. J Pediatr. 2020;221:165–173.e162. doi:10.1016/j.jpeds.2020.02.069
  • Große J, Hornstein H, Manuwald U, Kugler J, Glauche I, Rothe U. Incidence of diabetic ketoacidosis of new-onset type 1 diabetes in children and adolescents in different countries correlates with Human Development Index (HDI): an updated systematic review, meta-analysis, and meta-regression. Horm Metab Res. 2018;50(3):209–222. doi:10.1055/s-0044-102090
  • Miščević NJCJoP. United nations development programme, human development report 2020. The next frontier human development and the anthropocene. Croat J Philos. 2021;21(61):231–235.
  • Richardson CC, Dromey JA, McLaughlin KA, et al. High frequency of autoantibodies in patients with long duration type 1 diabetes. Diabetologia. 2013;56(11):2538–2540. doi:10.1007/s00125-013-3017-7
  • Patel SK, Ma CS, Fourlanos S, Greenfield JR. Autoantibody-negative type 1 diabetes: a neglected subtype. Trends Endocrinol Metab. 2021;32(5):295–305. doi:10.1016/j.tem.2021.02.001
  • Wenzlau JM, Juhl K, Yu L, et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci. 2007;104(43):17040–17045. doi:10.1073/pnas.0705894104
  • Danne T, Phillip M, Buckingham BA, et al. ISPAD clinical practice consensus guidelines 2018: insulin treatment in children and adolescents with diabetes. Pediatr Diabetes. 2018;19(Suppl 27):115–135. doi:10.1111/pedi.12718
  • American Diabetes Association. 13. children and adolescents: standards of medical care in diabetes—2021. Diabetes Care. 2021;44(Supplement 1):S180–S199. doi:10.2337/dc21-S013
  • Miller KM, Beck RW, Bergenstal RM, et al. Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants. Diabetes Care. 2013;36(7):2009–2014. doi:10.2337/dc12-1770
  • Ziegler R, Heidtmann B, Hilgard D, Hofer S, Rosenbauer J, Holl R. Frequency of SMBG correlates with HbA1c and acute complications in children and adolescents with type 1 diabetes. Pediatr Diabetes. 2011;12(1):11–17. doi:10.1111/j.1399-5448.2010.00650.x
  • Carlsen S, Skrivarhaug T, Thue G, et al. Glycemic control and complications in patients with type 1 diabetes - A registry-based longitudinal study of adolescents and young adults. Pediatr Diabetes. 2017;18(3):188–195. doi:10.1111/pedi.12372
  • Foster NC, Beck RW, Miller KM, et al. State of type 1 diabetes management and outcomes from the T1D exchange in 2016–2018. Diabetes Technol Ther. 2019;21(2):66–72. doi:10.1089/dia.2018.0384
  • Gerstl EM, Rabl W, Rosenbauer J, et al. Metabolic control as reflected by HbA1c in children, adolescents and young adults with type-1 diabetes mellitus: combined longitudinal analysis including 27,035 patients from 207 centers in Germany and Austria during the last decade. Eur J Pediatr. 2008;167(4):447–453. doi:10.1007/s00431-007-0586-9
  • Khandelwal S, Sengar GS, Sharma M, Choudhary S, Nagaraj N. Psychosocial illness in children with type 1 diabetes mellitus: prevalence, pattern and risk factors. J Clin Diagnostic Res. 2016;10(9):SC05–SC08. doi:10.7860/JCDR/2016/21666.8549
  • Cameron FJ, Garvey K, Hood KK, Acerini CL, Codner E. ISPAD clinical practice consensus guidelines 2018: diabetes in adolescence. Pediatr Diabetes. 2018;19(Suppl 27):250–261. doi:10.1111/pedi.12702
  • Song SH. Significant retinopathy in young-onset type 2 vs. type 1 diabetes: a clinical observation. Int J Clin Pract. 2016;70(10):853–860. doi:10.1111/ijcp.12789
  • Jaiswal M, Lauer A, Martin CL, et al. Peripheral neuropathy in adolescents and young adults with type 1 and type 2 diabetes from the SEARCH for diabetes in youth follow-up cohort: a pilot study. Diabetes Care. 2013;36(12):3903–3908. doi:10.2337/dc13-1213
  • Dart AB, Sellers EA, Martens PJ, Rigatto C, Brownell MD, Dean HJ. High burden of kidney disease in youth-onset type 2 diabetes. Diabetes Care. 2012;35(6):1265–1271. doi:10.2337/dc11-2312
  • Rajalakshmi R, Amutha A, Ranjani H, et al. Prevalence and risk factors for diabetic retinopathy in Asian Indians with young onset type 1 and type 2 diabetes. J Diabetes Complications. 2014;28(3):291–297. doi:10.1016/j.jdiacomp.2013.12.008
  • Mayer-Davis EJ, Davis C, Saadine J, et al. Diabetic retinopathy in the SEARCH for diabetes in youth cohort: a pilot study. Diabet Med. 2012;29(9):1148–1152. doi:10.1111/j.1464-5491.2012.03591.x
  • Eppens MC, Craig ME, Cusumano J, et al. Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes. Diabetes Care. 2006;29(6):1300–1306. doi:10.2337/dc05-2470
  • L Pyle. Rapid rise in hypertension and nephropathy in youth with type 2 diabetes: the TODAY clinical trial. Diabetes Care. 2013;36(6):1735–1741. doi:10.2337/dc12-2420
  • Solis-Herrera C, Triplitt CL, Lynch JL. Nephropathy in youth and young adults with type 2 diabetes. Curr Diab Rep. 2014;14(2):456. doi:10.1007/s11892-013-0456-y
  • Nathan DM. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview. Diabetes Care. 2014;37(1):9–16. doi:10.2337/dc13-2112